Psychedelic Drugs in Biomedicine
Trends in Pharmacological Sciences September 22, 2017 Evan J. Kyzar, Charles D. Nichols, Raul R. Gainetdinov et al. 155 citations
Psychedelic drugs, such as lysergic acid diethylamide (LSD), mescaline, and psilocybin, exert profound effects on brain and behavior. After decades of difficulties in studying these compounds, psychedelics are again being tested as potential treatments for intractable biomedical disorders. Preclinical research of psychedelics complements human neuroimaging studies and pilot clinical trials,...